GPNX
NOTIFICATION PROCESSED BY IB
10/30/2022
Back to search
Official data from USPTO
QREYDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
10/30/2022
Trademark type
Word
Nice classes
5
Filing date
09/24/2021
Registration date
08/30/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/30/2022
Last transaction
08/30/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
DE
Examiner
SPARACINO, MARK V
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Boehringer Ingelheim Corporate Center GmbH
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolismof the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disordersdamaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparationscell-based immune therapeutics for treatment of cancertreatment of immunological diseasestreatment of infectious diseases
Publications
History of USPTO decisions and trademark events.
13 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/12/2022
FIMP
FINAL DISPOSITION PROCESSED
10/12/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
09/29/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/30/2022
PUBO
PUBLISHED FOR OPPOSITION
06/14/2022
NPUB
NOTICE OF PUBLICATION
05/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2022
DOCK
ASSIGNED TO EXAMINER
05/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/20/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/13/2022
Continuous trademark protection
Get notified about every new filing that threatens QREYDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.